{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:41:44Z","timestamp":1787319704327,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.antiviral.2015.10.012","type":"journal-article","created":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T11:07:37Z","timestamp":1446548857000},"page":"61-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Antibody with an engineered Fc region as a therapeutic agent against dengue virus infection"],"prefix":"10.1016","volume":"124","author":[{"given":"Ririn","family":"Ramadhany","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itaru","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadahiro","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichiro","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pongrama","family":"Ramasoota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyoshi","family":"Ikuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4648-6419","authenticated-orcid":false,"given":"Takeshi","family":"Kurosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2015.10.012_bib1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev.immunol.25.022106.141702","article-title":"The impact of glycosilation on the biological function and structure of human immunoglobulins","volume":"25","author":"Arnold","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2015.10.012_bib2","doi-asserted-by":"crossref","first-page":"e1000790","DOI":"10.1371\/journal.ppat.1000790","article-title":"Lethal antibody enhancement of Dengue disease in mice is prevented by Fc modification","volume":"6","author":"Balsitis","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2015.10.012_bib3","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1128\/JVI.02484-07","article-title":"Role of dendritic cells in antibody-dependent enhancement of Dengue virus infection","volume":"82","author":"Boonak","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2015.10.012_bib4","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.4049\/jimmunol.1203052","article-title":"Human Fc\u03b3RII cytoplasmic domains differentially influence antibody-mediated dengue virus infection","volume":"190","author":"Boonnak","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2015.10.012_bib5","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4269\/ajtmh.1988.38.172","article-title":"A\u00a0prospective study of dengue infections in Bangkok","volume":"38","author":"Burke","year":"1988","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2015.10.012_bib6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1099\/vir.0.82537-0","article-title":"Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells","volume":"88","author":"Chareonsirisuthigul","year":"2007","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2015.10.012_bib7","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/jlb.49.6.556","article-title":"The human monocyte-like cell line THP-1 expresses Fc\u03b3RI and Fc\u03b3RII","volume":"49","author":"Fleit","year":"1991","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.antiviral.2015.10.012_bib8","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4269\/ajtmh.1999.61.412","article-title":"A\u00a0prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia I. studies in 1995-1996","volume":"61","author":"Graham","year":"1999","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2015.10.012_bib9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nri3582","article-title":"The function of Fc\u03b3 receptors in dendritic cells and macrophages","volume":"14","author":"Guilliams","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2015.10.012_bib10","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/glycob\/cwr047","article-title":"Isolation and characterization of IgG1 with asymmetrical Fc glycosylation","volume":"21","author":"Ha","year":"2011","journal-title":"Glycobiology"},{"key":"10.1016\/j.antiviral.2015.10.012_bib11","series-title":"Frontiers in Dengue Virus Research","first-page":"266","author":"Hanley","year":"2010"},{"key":"10.1016\/j.antiviral.2015.10.012_bib12","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1128\/iai.41.2.462-469.1983","article-title":"Enhancement of Dengue virus type 2 replication in mouse macrophage cultures by bacterial cell walls, peptidoglycans, and a polymer of peptidoglycan subunits","volume":"41","author":"Hotta","year":"1983","journal-title":"Infect. Immun."},{"key":"10.1016\/j.antiviral.2015.10.012_bib13","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1152\/ajprenal.0164.2001","article-title":"FcRn-mediated transcytosis of immunoglobulin G in human renal proximal tubular epithelial cells","volume":"282","author":"Kobayashi","year":"2002","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.antiviral.2015.10.012_bib14","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1128\/jvi.62.11.3928-3933.1988","article-title":"Interferon gamma augments Fc\u03b3receptor-mediated dengue virus infection of human monocytic cells","volume":"62","author":"Kontny","year":"1988","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2015.10.012_bib15","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.bbrc.2010.02.181","article-title":"Highly efficient rescue of dengue virus using a co-culture system with mosquito\/mammalian cells","volume":"394","author":"Kurosu","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2015.10.012_bib16","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.4049\/jimmunol.144.8.3183","article-title":"Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection","volume":"144","author":"Littaua","year":"1990","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2015.10.012_bib17","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.4049\/jimmunol.1200501","article-title":"Impact of immune complex size and glycosylation on IgG binding to human Fc\u03b3Rs","volume":"190","author":"Lux","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2015.10.012_bib18","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1099\/0022-1317-74-5-839","article-title":"Neuraminidase augments Fc\u03b3 receptor II-mediated antibody-dependent enhancement of dengue virus infection","volume":"74","author":"Mady","year":"1993","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2015.10.012_bib19","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1089\/vim.2012.0102","article-title":"Serotype-specific anti-dengue virus NS1 mouse antibodies cross-react with prM and are potentially involved in virus production","volume":"26","author":"Masrinoul","year":"2013","journal-title":"Viral Immunol."},{"key":"10.1016\/j.antiviral.2015.10.012_bib20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1099\/vir.0.014829-0","article-title":"Involvement of the Fc\u03b3 receptor IIA cytoplasmic domain in antibody-dependent enhancement of dengue virus infection","volume":"91","author":"Moi","year":"2010","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2015.10.012_bib22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1017\/S0022172400070923","article-title":"Immunological enhancement and the pathogenesis of dengue haemorrhagic fever","volume":"89","author":"Porterfield","year":"1982","journal-title":"J.\u00a0Hyg. Lond."},{"key":"10.1016\/j.antiviral.2015.10.012_bib23","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev.immunol.19.1.275","article-title":"IgG fc receptors","volume":"19","author":"Ravetch","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2015.10.012_bib24","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1128\/JVI.00792-06","article-title":"Differential enhancement of dengue virus immune complex infectivity mediated by signaling-competent and signaling-incompetent human Fc\u03b3RIA (CD64) or Fc\u03b3RIIA (CD32)","volume":"80","author":"Rodrigo","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2015.10.012_bib25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jviromet.2007.02.011","article-title":"Development and evaluation of SYBR Green I-based one-step real-time RT-PCR assay for detection and quantitation of Japanese encephalitis virus","volume":"143","author":"Santhosh","year":"2007","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.antiviral.2015.10.012_bib26","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.antiviral.2013.03.018","article-title":"Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection","volume":"98","author":"Sasaki","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2015.10.012_bib27","doi-asserted-by":"crossref","first-page":"20167","DOI":"10.1073\/pnas.0809257105","article-title":"Aglycosilated immunoglobulin G1 variants productively engage activating Fc receptors","volume":"105","author":"Sazinsky","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.antiviral.2015.10.012_bib28","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.bbrc.2012.06.057","article-title":"Human monoclonal antibodies to neutralize all dengue virus serotypes using lymphocytes from patients at acute phase of the secondary infection","volume":"423","author":"Setthapramote","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2015.10.012_bib29","doi-asserted-by":"crossref","first-page":"6591","DOI":"10.1074\/jbc.M009483200","article-title":"High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R","volume":"276","author":"Shields","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2015.10.012_bib30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.imlet.2006.05.009","article-title":"Molecular aspects of human Fc\u03b3R interactions with IgG: functional and therapeutics consequences","volume":"106","author":"Siberil","year":"2006","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.antiviral.2015.10.012_bib32","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.imbio.2008.11.008","article-title":"Role of antibodies in controlling dengue virus infection","volume":"214","author":"van der Schaar","year":"2009","journal-title":"Immunobiology"},{"key":"10.1016\/j.antiviral.2015.10.012_bib33","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/315215","article-title":"Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity","volume":"181","author":"Vaughn","year":"2000","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.10.012_bib34","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.3390\/v3122374","article-title":"Review: the human antibody response to dengue virus infection","volume":"3","author":"Wahala","year":"2011","journal-title":"Viruses"},{"issue":"39","key":"10.1016\/j.antiviral.2015.10.012_bib35","doi-asserted-by":"crossref","first-page":"9698","DOI":"10.1021\/bi000749m","article-title":"Crystal structure and immunoglobulin G binding properties of the human major histocompatibility complex-related Fc receptor","volume":"2000","author":"West","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2015.10.012_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2011.07.022","article-title":"The pathogenesis of dengue","volume":"29","author":"Whitehorn","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2015.10.012_bib37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0167-7799(96)10062-7","article-title":"Effect of glycosylation on antibody function: implication for genetic engineering","volume":"15","author":"Wright","year":"1997","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.antiviral.2015.10.012_bib38","doi-asserted-by":"crossref","first-page":"e1003150","DOI":"10.1371\/journal.ppat.1003150","article-title":"Human monoclonal antibodies broadly protective against influenza B virus","volume":"9","author":"Yasugi","year":"2013","journal-title":"PLoS Pathog."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215300139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215300139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T14:38:37Z","timestamp":1692110317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354215300139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":36,"alternative-id":["S0166354215300139"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.10.012","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody with an engineered Fc region as a therapeutic agent against dengue virus infection","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}